Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
93.65
+0.41 (0.44%)
At close: Aug 19, 2026, 4:00 PM EDT
93.68
+0.03 (0.03%)
After-hours: Aug 19, 2026, 7:54 PM EDT
Celcuity Employees
Celcuity had 155 employees as of December 31, 2025. The number of employees increased by 68 or 78.16% compared to the previous year.
Employees
155
Change (1Y)
68
Growth (1Y)
78.16%
Revenue / Employee
n/a
Profits / Employee
-$1,461,174
Market Cap
4.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 155 | 68 | 78.16% |
| Dec 31, 2024 | 87 | 32 | 58.18% |
| Dec 31, 2023 | 55 | 10 | 22.22% |
| Dec 31, 2022 | 45 | 6 | 15.38% |
| Dec 31, 2021 | 39 | 9 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 289 |
| Relay Therapeutics | 202 |
| Parabilis Medicines | 145 |
| Tango Therapeutics | 137 |
| Edgewise Therapeutics | 127 |
CELC News
- 2 days ago - Celcuity price target raised to $175 from $165 at Guggenheim - TheFly
- 3 days ago - Celcuity reports Q2 EPS ($1.07), consensus ($1.16) - TheFly
- 3 days ago - Celcuity price target lowered to $150 from $175 at Stifel - TheFly
- 3 days ago - Celcuity price target lowered to $140 from $157 at Needham - TheFly
- 6 days ago - Celcuity Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - Celcuity Earnings release: Q2 2026 - Filings
- 6 days ago - Celcuity Quarterly report: Q2 2026 - Filings
- 6 days ago - Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire